Consequences of cholecystectomy and principles of their correction and prevention

Author: I.E. Kushnir, Ph. med. n., State Institution “National Institute of Therapy named after L.T. Minor NAMS of Ukraine”, Kharkov


In recent decades, there has been an increase in the prevalence of gallstone disease (GSD) among the adult population of the world. The number of patients with housing and communal services, according to population studies, is 10-15% and increases by 2 times every 10 years. The increase in the number of patients with HCS is due to the influence of modified risk factors, especially dietary habits with fiber deficiency in the diet and food excesses, especially the consumption of “fast” carbohydrates, high levels of obesity, a sedentary lifestyle, and the presence of concomitant metabolic diseases.

Today, different approaches are used to treat patients with HUS, in particular, the use of litholytic drugs, shock wave lithotripsy, and a surgical method. The latter method, in particular laparoscopic cholecystectomy, is considered the gold standard for the treatment of patients with GI. More than 2.5 million cholecystectomy interventions are performed annually in the world: in European countries – from 45 to 80 thousand, in the USA – more than 700 thousand, in Russia – about 500 thousand. However, unfortunately, cholecystectomy (CE) is not a radical a method that allows you to completely get rid of the symptoms of HCS. In 30.0-79.2% of patients who underwent CE for housing and communal services, various complaints remain or arise some time after surgery (abdominal discomfort, pain, dyspeptic disorders), which necessitate the appointment of drug treatment.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design